Predictor factor of survival in advanced hepatocellular carcinoma treated with sorafenib ∼a multicenter study∼

被引：0
|
作者：
Ogawa, Chikara [1 ,6 ]
Morita, Masahiro [1 ]
Omura, Akina [1 ]
Shibatoge, Mitsushige [1 ]
Tsutsui, Akemi [2 ]
Senoh, Tomonori [2 ]
Nagano, Takuya [2 ]
Takaguchi, Kouichi [2 ]
Tani, Joji [3 ]
Morishita, Asahiro [3 ]
Yoneyama, Hirohito [3 ]
Masaki, Tsutomu [3 ]
Moriya, Akio [4 ]
Ando, Masaharu [4 ]
Deguchi, Akihiro [5 ]
Kudo, Masatoshi [6 ]
机构：
[1] Takamatsu Red Cross Hosp, Dept Gastroenterol & Hepatol, Takamatsu, Kagawa, Japan
[2] Kagawa Prefectural Cent Hosp, Dept Hepatol, Takamatsu, Kagawa, Japan
[3] Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, Takamatsu, Kagawa, Japan
[4] Mitoyo Gen Hosp, Dept Gastroenterol, Kanonji, Japan
[5] Kagawa Rosai Hosp, Dept Gastroenterol, Marugame, Japan
[6] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, Higashiosaka, Osaka, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O1-6-4
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sarcopenia is not a predictor of survival or sorafenib toxicity in advanced hepatocellular carcinoma: A Dutch multicenter study
    Labeur, T.
    van Vugt, J.
    Cate, D. T.
    Takkenberg, B.
    Koerkamp, B. G.
    Man, R. D.
    van Delden, O.
    Ijzermans, J.
    Eskens, F.
    Klumpen, H. -J.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S434 - S434
  • [2] The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib
    Caputo, Francesco
    Dadduzio, Vincenzo
    Tovoli, Francesco
    Bertolini, Giulia
    Cabibbo, Giuseppe
    Cerma, Krisida
    Vivaldi, Caterina
    Faloppi, Luca
    Rizzato, Mario Domenico
    Piscaglia, Fabio
    Celsa, Ciro
    Fornaro, Lorenzo
    Marisi, Giorgia
    Conti, Fabio
    Silvestris, Nicola
    Silletta, Marianna
    Lonardi, Sara
    Granito, Alessandro
    Stornello, Caterina
    Massa, Valentina
    Astara, Giorgio
    Delcuratolo, Sabina
    Cascinu, Stefano
    Scartozzi, Mario
    Casadei-Gardini, Andrea
    [J]. PLOS ONE, 2020, 15 (05):
  • [3] Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with Sorafenib
    Antonelli, G.
    Gigante, E.
    Iavarone, M.
    Begini, P.
    Biondetti, P.
    Pellicelli, A. M.
    Sangiovanni, A.
    Lampertico, P.
    Marignani, M.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S207 - S208
  • [4] Skin toxicities and survival in advanced hepatocellular carcinoma patients treated with sorafenib
    Otsuka, Taiga
    Eguchi, Yuichiro
    Kawazoe, Seiji
    Yanagita, Kimihiko
    Ario, Keisuke
    Kitahara, Kenji
    Kawasoe, Hiroaki
    Kato, Hiroyuki
    Mizuta, Toshihiko
    [J]. HEPATOLOGY RESEARCH, 2012, 42 (09) : 879 - 886
  • [5] TIME TO PROGRESSION TO AFP AS A PREDICTOR OF SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB
    Varela, M.
    Castano-Fernandez, O.
    Blanco Garcia, L.
    Mesa-Alvarez, A.
    Menendez de Llano, R.
    Sanmartino, S.
    Argueelles, B.
    Martinez-Camblor, P.
    Luyando, L. H.
    Rodriguez, M.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S116 - S117
  • [6] Analysis of postprogression survival of patients with advanced hepatocellular carcinoma treated with sorafenib
    Wada, Y.
    Takami, Y.
    Matsushima, H.
    Ryu, T.
    Mikagi, K.
    Saitsu, H.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S630 - S631
  • [7] Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Antonelli, G.
    Gigante, E.
    Iavarone, M.
    Begini, P.
    Sangiovanni, A.
    Iannicelli, E.
    Biondetti, P.
    Pellicelli, A. M.
    Miglioresi, L.
    Marchetti, P.
    Lampertico, P.
    Marignani, M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 14 - 14
  • [8] Monitoring of Plasma Vascular Endothelial Growth Factor after Sorafenib Administration as Predictor of Survival in Advanced Hepatocellular Carcinoma
    Tsuchiya, Kaoru
    Yasui, Yutaka
    Matsuda, Shuya
    Muraoka, Masaru
    Tamaki, Nobuharu
    Suzuki, Shoko
    Hosokawa, Takanori
    Ueda, Ken
    Nakanishi, Hiroyuki
    Itakura, Jun
    Takahashi, Yuka
    Kurosaki, Masayuki
    Asahina, Yasuhiro
    Izumi, Namiki
    [J]. HEPATOLOGY, 2013, 58 : 1260A - 1260A
  • [9] A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study
    Marasco, Giovanni
    Poggioli, Francesco
    Colecchia, Antonio
    Cabibbo, Giuseppe
    Pelizzaro, Filippo
    Giannini, Edoardo Giovanni
    Marinelli, Sara
    Rapaccini, Gian Ludovico
    Caturelli, Eugenio
    Di Marco, Mariella
    Biasini, Elisabetta
    Marra, Fabio
    Morisco, Filomena
    Foschi, Francesco Giuseppe
    Zoli, Marco
    Gasbarrini, Antonio
    Svegliati Baroni, Gianluca
    Masotto, Alberto
    Sacco, Rodolfo
    Raimondo, Giovanni
    Azzaroli, Francesco
    Mega, Andrea
    Vidili, Gianpaolo
    Brunetto, Maurizia Rossana
    Nardone, Gerardo
    Alemanni, Luigina Vanessa
    Dajti, Elton
    Ravaioli, Federico
    Festi, Davide
    Trevisani, Franco
    [J]. CANCERS, 2021, 13 (11)
  • [10] Relationship of ethnicity and overall survival in patients treated with sorafenib for advanced hepatocellular carcinoma
    Peixoto, Renata D'Alpino
    Renouf, Daniel J.
    Gill, Sharlene
    Cheung, Winson Y.
    Lim, Howard J.
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2014, 5 (04) : 259 - 264
12345